News
Tirzepatide may confer larger increases in testosterone levels among men with metabolic hypogonadism than testosterone ...
A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...
Men receiving tirzepatide showed greater reductions in body weight and waist circumference and improvements in erectile ...
Tirzepatide yielded greater cardiometabolic benefits, especially in total cholesterol, LDL cholesterol, and weight loss, among women than men.
Tirzepatide helps obese adults lose over 15% of body weight in 52 weeks—and retain much of it even six months after stopping ...
Eli Lilly ( LLY 0.64%) has been one of the best-performing pharmaceutical leaders in the past five years. Thanks to strong ...
Explore more
Roughly one in three preteens and teens ages 12 to 17 in the United States had prediabetes in 2023, according to new data ...
GLP-1 drugs for diabetes and weight loss are difficult for some people to inject weekly. A new slow-release gel, tested in rats, could help.
Tirzepatide was superior to semaglutide in achieving standard and intensive cardiometabolic targets among patients with type 2 diabetes.
(1276.HK; 600276.SH) delivered a piece of good news for investors with positive trial data for a dual-acting obesity drug ...
Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body weight, food intake and many measures of appetite more than placebo and ...
11d
News-Medical.Net on MSNTirzepatide reduces obesity-associated breast cancer growth in mouse modelThe anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results